Costa Rica signs COVID-19 vaccine deal with Pfizer and BioNTech

[ad_1]

FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus Vaccine / Injection Only” and a medical syringe are seen in front of a Pfizer logo displayed in this illustration taken October 31, 2020. REUTERS / Dado Ruvic

Race for a cure

Reuters staff

SAN JOSE (Reuters) – Costa Rica has signed an agreement with pharmaceutical companies Pfizer Inc and its German partner BioNTech SE to manufacture and deliver 3 million COVID-19 vaccines next year, the office of the president Carlos Alvarado.

Deliveries will be made throughout the four quarters of 2021, as scheduled in an initial agreement announced on Oct. 1, the president’s office said in a statement.

The deal will allow Costa Rica to deliver two doses to 1.5 million people and follows agreements with AstraZeneca and the Covax mechanism backed by the World Health Organization. In total, the agreements are expected to cover around 3 million people, or nearly 60% of the Costa Rican population.

The Central American country has so far recorded some 142,505 coronavirus cases and 1,757 related deaths.

[ad_2]

Source link